GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (XSAT:ENZY) » Definitions » Cyclically Adjusted PB Ratio

Enzymatica AB (XSAT:ENZY) Cyclically Adjusted PB Ratio : (As of Jun. 11, 2024)


View and export this data going back to . Start your Free Trial

What is Enzymatica AB Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzymatica AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Enzymatica AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Cyclically Adjusted PB Ratio Chart

Enzymatica AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 16.28 7.17 3.32 2.86

Enzymatica AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 1.87 2.46 2.86 2.36

Competitive Comparison of Enzymatica AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymatica AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's Cyclically Adjusted PB Ratio falls into.



Enzymatica AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Enzymatica AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Enzymatica AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.362/132.2054*132.2054
=3.362

Current CPI (Mar. 2024) = 132.2054.

Enzymatica AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.209 100.432 4.224
201409 2.995 100.161 3.953
201412 2.501 100.225 3.299
201503 2.140 99.950 2.831
201506 1.730 99.995 2.287
201509 1.325 100.228 1.748
201512 0.881 100.276 1.162
201603 0.556 100.751 0.730
201606 5.220 101.019 6.831
201609 6.390 101.138 8.353
201612 5.676 102.022 7.355
201703 5.230 102.022 6.777
201706 4.803 102.752 6.180
201709 4.656 103.279 5.960
201712 4.420 103.793 5.630
201803 4.061 103.962 5.164
201806 3.441 104.875 4.338
201809 3.038 105.679 3.801
201812 6.396 105.912 7.984
201903 5.904 105.886 7.372
201906 5.266 106.742 6.522
201909 5.006 107.214 6.173
201912 4.775 107.766 5.858
202003 4.771 106.563 5.919
202006 4.384 107.498 5.392
202009 4.300 107.635 5.282
202012 4.273 108.296 5.216
202103 3.966 108.360 4.839
202106 5.528 108.928 6.709
202109 5.380 110.338 6.446
202112 5.007 112.486 5.885
202203 4.316 114.825 4.969
202206 3.737 118.384 4.173
202209 0.586 122.296 0.633
202212 5.060 126.365 5.294
202303 4.489 127.042 4.671
202306 4.059 129.407 4.147
202309 3.689 130.224 3.745
202312 3.069 131.912 3.076
202403 3.362 132.205 3.362

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzymatica AB  (XSAT:ENZY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Enzymatica AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymatica AB (XSAT:ENZY) Business Description

Traded in Other Exchanges
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB (XSAT:ENZY) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016